Down-Regulation of Brain-Pancreas Relative Protein in Diabetic Rats and by High Glucose in PC12 Cells: Prevention by Calpain Inhibitors

Brain-pancreas relative protein (BPRP) is a novel protein that we found in our laboratory. Previously we demonstrated that it is involved in ischemia and depression. In light of the putative association between diabetes and clinical depression, and the selective expression of BPRP in brain and pancr...

Full description

Saved in:
Bibliographic Details
Main Authors: Lu Tie (Author), Ying Xu (Author), Yan-Hua Lin (Author), Xiao-Hao Yao (Author), Hong-Li Wu (Author), Yu-Hua Li (Author), Zhu-Fang Shen (Author), He-Ming Yu (Author), Xue-Jun Li (Author)
Format: Book
Published: Elsevier, 2008-01-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_ae17f056d3b04b7e87d510c9155e334f
042 |a dc 
100 1 0 |a Lu Tie  |e author 
700 1 0 |a Ying Xu  |e author 
700 1 0 |a Yan-Hua Lin  |e author 
700 1 0 |a Xiao-Hao Yao  |e author 
700 1 0 |a Hong-Li Wu  |e author 
700 1 0 |a Yu-Hua Li  |e author 
700 1 0 |a Zhu-Fang Shen  |e author 
700 1 0 |a He-Ming Yu  |e author 
700 1 0 |a Xue-Jun Li  |e author 
245 0 0 |a Down-Regulation of Brain-Pancreas Relative Protein in Diabetic Rats and by High Glucose in PC12 Cells: Prevention by Calpain Inhibitors 
260 |b Elsevier,   |c 2008-01-01T00:00:00Z. 
500 |a 1347-8613 
500 |a 10.1254/jphs.FP0071092 
520 |a Brain-pancreas relative protein (BPRP) is a novel protein that we found in our laboratory. Previously we demonstrated that it is involved in ischemia and depression. In light of the putative association between diabetes and clinical depression, and the selective expression of BPRP in brain and pancreas, the present study examined whether BPRP levels are affected by induction of diabetes by alloxan injection in rats and exposure to high glucose levels in PC12 cells. Western blot and immunohistochemical analyses revealed that BPRP levels were decreased in the hippocampal CA1 neurons of diabetic rats 4 and 8 weeks post-alloxan injection and in PC12 cells 48 h after exposure to high concentrations of glucose. BPRP protein levels were not affected by osmolarity control treatments with mannitol. Follow-up pharmacological experiments in PC12 cells revealed that glucose-induced BPRP down-regulation was markedly attenuated by the calpain inhibitors N-acetyl-Leu-Leu-norleucinal (ALLN) or calpeptin, but not the proteasome-specific inhibitor carbobenzoxy-Leu-Leu-leucinal (MG132). The ability of calpain inhibitors to specifically counter the effects of high glucose exposure on BPRP levels further suggests that BPRP and calpain activity may contribute to diabetes complications in the central nervous system. Keywords:: brain-pancreas relative protein, diabetes, high glucose, proteasome inhibitor, calpeptin 
546 |a EN 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Journal of Pharmacological Sciences, Vol 106, Iss 1, Pp 28-37 (2008) 
787 0 |n http://www.sciencedirect.com/science/article/pii/S1347861319315336 
787 0 |n https://doaj.org/toc/1347-8613 
856 4 1 |u https://doaj.org/article/ae17f056d3b04b7e87d510c9155e334f  |z Connect to this object online.